| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.68B | 84.41B | 82.11B | 83.86B | 80.14B | 84.92B |
| Gross Profit | 20.62B | 20.28B | 16.86B | 18.48B | 21.05B | 17.22B |
| EBITDA | 9.71B | 9.76B | 767.00M | 9.61B | 13.76B | 2.43B |
| Net Income | 4.87B | 5.01B | -7.09B | 2.34B | 6.75B | -2.80B |
Balance Sheet | ||||||
| Total Assets | 123.36B | 123.32B | 125.44B | 128.02B | 123.92B | 123.01B |
| Cash, Cash Equivalents and Short-Term Investments | 16.39B | 16.18B | 16.59B | 12.41B | 10.80B | 11.09B |
| Total Debt | 22.98B | 21.92B | 27.04B | 21.64B | 16.96B | 20.44B |
| Total Liabilities | 45.67B | 43.93B | 49.98B | 43.31B | 41.21B | 43.74B |
| Stockholders Equity | 76.64B | 78.29B | 74.39B | 80.49B | 78.85B | 75.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.06B | 2.84B | -1.89B | 1.50B | -1.74B |
| Operating Cash Flow | 0.00 | 12.01B | 6.87B | 773.00M | 6.57B | 7.83B |
| Investing Cash Flow | 0.00 | -5.71B | -3.96B | -2.62B | -1.65B | -7.42B |
| Financing Cash Flow | 0.00 | -6.88B | 1.26B | 3.28B | -5.65B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥279.93B | 22.17 | ― | 1.02% | -3.06% | 45.21% | |
74 Outperform | ¥109.95B | 7.90 | ― | 4.18% | 1.16% | 167.89% | |
70 Outperform | ¥52.00B | 7.99 | ― | 4.46% | -1.09% | ― | |
68 Neutral | ¥73.61B | 11.90 | ― | 3.75% | -0.68% | -9.93% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥59.11B | 30.77 | ― | 1.65% | 1.20% | ― |
Sakai Chemical Industry Co., Ltd. has completed the acquisition of its own shares, purchasing a total of 914,000 shares at a cost of approximately 2.5 billion yen. This strategic move, resolved by the Board of Directors, aims to enhance shareholder value and involves plans to cancel all acquired treasury shares, potentially impacting the company’s stock market positioning and shareholder equity.
Sakai Chemical Industry Co., Ltd. reported a decrease in net sales by 4.3% for the second quarter of 2025 compared to the same period in 2024. Despite the decline in sales, the company experienced a significant increase in operating profit by 25.1% and profit attributable to owners of the parent by 67.5%, indicating improved operational efficiency and profitability.
Sakai Chemical Industry Co., Ltd. announced the results of its share acquisition program, which was resolved by the Board of Directors in May 2025. The company acquired 102,600 common shares for 291,919,100 yen between October 1 and October 31, 2025, through market purchases on the Tokyo Stock Exchange. This acquisition is part of a broader plan to acquire up to 1,000,000 shares, with the intent to cancel all treasury shares acquired, reflecting a strategic move to optimize capital structure and potentially enhance shareholder value.
Sakai Chemical Industry Co., Ltd. announced the results of its share buyback program, acquiring 59,000 common shares at a cost of 172,571,300 yen between September 1 and September 30, 2025. This acquisition is part of a broader plan approved by the Board of Directors to repurchase up to 1,000,000 shares, with the intention to cancel all acquired treasury shares, potentially impacting shareholder value and market perception.